Continuous Glucose Monitoring Technologies

Learn how to optimize outcomes in persons with diabetes using continuous glucose monitoring.
Elyse Marriner, BSN, RN, CDCES
Format: Microsoft PowerPoint (.ppt)
File Size: 2.84 MB
Released: July 7, 2021

Acknowledgements

Provided by the Endocrine Society in collaboration with the ADCES

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Abbott Diabetes
Medtronic
Novo Nordisk Inc.

Related Content

Downloadable slides from Clinical Care Options (CCO) featuring expert insights on the clinical trial data supporting the use of tirzepatide in T2D

Carol Hatch Wysham, MD Released: September 2, 2021

From Dr. Carol Hatch Wysham and Clinical Care Options (CCO), expert commentary on the role of obesity in the pathogenesis of type 2 diabetes

Carol Hatch Wysham, MD Released: September 2, 2021

Slides from Ananda Basu, MD, FRCP, and CCO: Case Studies in Continuous Glucose Monitoring

Ananda Basu, MD, FRCP
Program Director
Released: August 30, 2021

Slides from CCO: metabolic adaptations in obesity, value of sustained weight loss, and latest evidence for incretin-based therapies

Randy J. Seeley, PhD Jenny Tong, MD, MPH Kristina M. Utzschneider, MD Released: August 18, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue